We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
-13.79%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
10 Year Est. Return
AUM
$273M
AUM Growth
-$31M
Cap. Flow
+$3.24M
Cap. Flow %
1.19%
Top 10 Hldgs %
41.92%
Holding
103
New
39
Increased
16
Reduced
16
Closed
28

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$8.47M
2
MDVN
MEDIVATION, INC.
MDVN
+$7.8M
3
MDT icon
Medtronic
MDT
+$7.53M
4
HCA icon
HCA Healthcare
HCA
+$6.98M
5
PFE icon
Pfizer
PFE
+$6.02M

Sector Composition

Rank Sector Weight
1 Healthcare 67.79%
2 Industrials 0.39%
3 Consumer Staples 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDRX
26
DELISTED
Veradigm Inc. Common Stock
MDRX
$3.3M 1.21%
250,000
-25,000
-9% -$328K
BMY icon
27
CALL
Bristol-Myers Squibb
BMY
$130B
$3.19M 1.17%
+50,000
New +$3.15M
INCY icon
28
CALL
Incyte
INCY
$24.5B
$2.9M 1.06%
+40,000
New +$2.98M
ADMS
29
DELISTED
Adamas Pharmaceuticals
ADMS
$2.89M 1.06%
200,000
+140,000
+233% +$2.36M
REGN icon
30
Regeneron Pharmaceuticals
REGN
$82.1B
$2.7M 0.99%
+7,500
New +$3.09M
REGN icon
31
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
$2.7M 0.99%
+7,500
New +$3.09M
DVAX
32
DELISTED
Dynavax Technologies
DVAX
$2.69M 0.99%
+140,000
New +$2.83M
MRK icon
33
PUT
Merck
MRK
$322B
$2.65M 0.97%
+52,400
New +$2.57M
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$13.5B
$2.47M 0.91%
+30,000
New +$2.44M
KITE
35
DELISTED
Kite Pharma, Inc.
KITE
$2.3M 0.84%
+50,000
New +$2.42M
TVTY
36
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$2.27M 0.83%
225,000
CHRS icon
37
Coherus Oncology
CHRS
$187M
$2.12M 0.78%
100,000
+25,000
+33% +$410K
GKOS icon
38
Glaukos
GKOS
$10.7B
$2.11M 0.77%
+125,000
New +$2.17M
ADAP
39
DELISTED
Adaptimmune Therapeutics
ADAP
$2.03M 0.74%
250,000
-103,161
-29% -$844K
BKD icon
40
Brookdale Senior Living
BKD
$3B
$1.99M 0.73%
125,000
-25,000
-17% -$381K
XLRN
41
DELISTED
Acceleron Pharma
XLRN
$1.98M 0.73%
75,000
-75,000
-50% -$2.18M
GWPH
42
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.8M 0.66%
+25,000
New +$1.37M
AXDX
43
DELISTED
Accelerate Diagnostics
AXDX
$1.8M 0.66%
12,500
-5,000
-29% -$706K
MDVN
44
CALL
DELISTED
MEDIVATION, INC.
MDVN
$1.61M 0.59%
+35,000
New +$1.27M
IPXL
45
DELISTED
Impax Laboratories, Inc.
IPXL
$1.6M 0.59%
50,000
SPNC
46
DELISTED
Spectranetics Corp
SPNC
$1.6M 0.59%
110,000
+60,000
+120% +$831K
ALNY icon
47
PUT
Alnylam Pharmaceuticals
ALNY
$29.6B
$1.57M 0.57%
+25,000
New +$1.66M
MZOR
48
DELISTED
Mazor Robotics Ltd.
MZOR
$1.55M 0.57%
125,000
+100,000
+400% +$1.03M
DERM
49
DELISTED
Dermira, Inc.
DERM
$1.55M 0.57%
75,000
LDRH
50
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$1.53M 0.56%
+60,000
New +$1.26M

Similar funds

Iguana Healthcare Management's Q1 2016 Portfolio in Review

As of Q1 2016, Iguana Healthcare Management held 103 positions worth $273M, down 10% from $304M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Iguana Healthcare Management's Q1 2016 filing shows 39 new, 16 increased, 16 reduced and 28 closed positions. Its largest new stake was Zimmer Biomet: 87,550 shares worth $9.06M. The largest sale was Viatris, an estimated $12.2M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 78% a quarter earlier, followed by Industrials and Consumer Staples.

  • Iguana Healthcare Management's largest Q1 2016 buy was Zimmer Biomet: 87,550 shares worth $9.06M.
  • Iguana Healthcare Management added most to MEDIVATION, INC. in Q1 2016, an estimated $7.8M increase.
  • Iguana Healthcare Management's biggest Q1 2016 reduction was Amgen, cutting an estimated $9.66M.
  • Iguana Healthcare Management fully exited Viatris in Q1 2016, selling an estimated $12.2M.
  • Iguana Healthcare Management's ten largest holdings make up 42% of its $273M portfolio in Q1 2016.
  • Iguana Healthcare Management opened 39 new positions and closed 28 in Q1 2016.
  • Iguana Healthcare Management's portfolio value fell 10% quarter-over-quarter to $273M.

Based on Iguana Healthcare Management's 13F filing for Q1 2016, filed 17 May 2016.